Health Canada inspection
North China Pharmaceutical Group Semisyntech Co., Ltd.: Health Canada inspection of May 28, 2021
Health Canada · GMP · rating C
Key facts
| Establishment | North China Pharmaceutical Group Semisyntech Co., Ltd. |
|---|---|
| City | Shijiazhuang |
| Province | Hebei |
| Country | China |
| Program | GMP |
| Start date | May 24, 2021 |
| End date | May 28, 2021 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.